US20200398978A1 - Low-drag rotor blade extension - Google Patents

Low-drag rotor blade extension Download PDF

Info

Publication number
US20200398978A1
US20200398978A1 US16/447,421 US201916447421A US2020398978A1 US 20200398978 A1 US20200398978 A1 US 20200398978A1 US 201916447421 A US201916447421 A US 201916447421A US 2020398978 A1 US2020398978 A1 US 2020398978A1
Authority
US
United States
Prior art keywords
rotor
extension
connector
blade
rotorcraft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/447,421
Inventor
Jared Mark Paulson
Glenn Alan Shimek
Tom Donovan
Michael Christopher Burnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Textron Innovations Inc
Bell Textron Rhode Island Inc
Original Assignee
Bell Helicopter Textron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bell Helicopter Textron Inc filed Critical Bell Helicopter Textron Inc
Priority to US16/447,421 priority Critical patent/US20200398978A1/en
Assigned to BELL HELICOPTER TEXTRON INC. reassignment BELL HELICOPTER TEXTRON INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Burnett, Michael Christopher, DONOVAN, TOM, SHIMEK, Glenn Alan, PAULSON, Jared Mark
Priority to US17/025,371 priority patent/US11358711B2/en
Publication of US20200398978A1 publication Critical patent/US20200398978A1/en
Assigned to TEXTRON INNOVATIONS INC. reassignment TEXTRON INNOVATIONS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BELL TEXTRON RHODE ISLAND INC.
Assigned to BELL TEXTRON RHODE ISLAND INC. reassignment BELL TEXTRON RHODE ISLAND INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Bell Textron Inc.
Assigned to Bell Textron Inc. reassignment Bell Textron Inc. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BELL HELICOPTER TEXTRON INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B64AIRCRAFT; AVIATION; COSMONAUTICS
    • B64CAEROPLANES; HELICOPTERS
    • B64C11/00Propellers, e.g. of ducted type; Features common to propellers and rotors for rotorcraft
    • B64C11/02Hub construction
    • B64C11/04Blade mountings
    • B64C11/08Blade mountings for non-adjustable blades
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B64AIRCRAFT; AVIATION; COSMONAUTICS
    • B64CAEROPLANES; HELICOPTERS
    • B64C11/00Propellers, e.g. of ducted type; Features common to propellers and rotors for rotorcraft
    • B64C11/02Hub construction
    • B64C11/04Blade mountings
    • B64C11/08Blade mountings for non-adjustable blades
    • B64C11/10Blade mountings for non-adjustable blades rigid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B64AIRCRAFT; AVIATION; COSMONAUTICS
    • B64CAEROPLANES; HELICOPTERS
    • B64C27/00Rotorcraft; Rotors peculiar thereto
    • B64C27/32Rotors
    • B64C27/46Blades
    • B64C27/473Constructional features
    • B64C27/48Root attachment to rotor head
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Aviation & Aerospace Engineering (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Mechanical Engineering (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Turbine Rotor Nozzle Sealing (AREA)

Abstract

A rotorcraft includes a rotor hub coupled to a mast and a plurality of rotor extensions. Each rotor extension is configured to secure a rotor blade to the rotor hub and includes a first connector configured to attach the rotor extension to a rotor blade, a second connector configured to attach the rotor extension to the rotor hub; a shaft disposed between the first and second connectors, and a damper mount attached to the second connector. The rotorcraft also includes a fairing enclosing the damper and at least a portion of the rotor hub.

Description

    BACKGROUND
  • This section provides background information to facilitate a better understanding of the various aspects of the disclosure. It should be understood that the statements in this section of this document are to be read in this light, and not as admissions of prior art.
  • Drag is a key factor that limits the performance of a helicopter, particularly its top speed. Drag opposes the motion of a helicopter as the helicopter moves through the air. The total amount of drag acting upon a helicopter results from the summation of profile drag, induced drag, and parasitic drag. Profile drag is caused by the frictional resistance of the rotor blades passing through air. Induced drag is caused by the circulation of air around the rotor blade as lift is generated by the rotor blade. Parasitic drag is caused by the movement of non-lift generating components through air. Parasitic drag varies with the square of the velocity of the helicopter, making it a large component of the total amount of drag acting on a high-speed helicopter (e.g., helicopters that achieve speeds of 180 knots or more).
  • SUMMARY
  • An example of a low-drag rotor extension for a rotorcraft includes a first connector configured to attach the rotor extension to a rotor blade, a second connector configured to attach the rotor extension to a rotor hub of the rotorcraft, a shaft disposed between the first and second connectors, and a damper mount attached to the second connector.
  • An example of a low-drag rotorcraft includes a rotor hub coupled to a mast and a plurality of rotor extensions. Each rotor extension is configured to secure a rotor blade to the rotor hub and includes a first connector configured to attach the rotor extension to a rotor blade, a second connector configured to attach the rotor extension to the rotor hub; a shaft disposed between the first and second connectors, and a damper mount attached to the second connector. The rotorcraft also includes a fairing enclosing the damper and at least a portion of the rotor hub.
  • This summary is provided to introduce a selection of concepts that are further described below in the detailed description. This summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used as an aid in limiting the scope of claimed subject matter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The disclosure is best understood from the following detailed description when read with the accompanying figures. It is emphasized that, in accordance with standard practice in the industry, various features are not drawn to scale. In fact, the dimensions of various features may be arbitrarily increased or reduced for clarity of discussion.
  • FIG. 1 illustrates a rotorcraft in accordance with aspects of the disclosure;
  • FIGS. 2A and 2B illustrate top and side views, respectively, of a faired rotor system in accordance with aspects of the disclosure;
  • FIGS. 3A and 3B illustrate a rotor extension in accordance with aspects of the disclosure;
  • FIG. 4 is a comparative view of a traditional rotor blade and a rotor blade that includes the rotor extension of FIGS. 3A and 3B in accordance with aspects of the disclosure;
  • FIGS. 5A and 5B illustrate a rotor extension in accordance with aspects of the disclosure; and
  • FIG. 6 is a comparative view of a traditional rotor blade and a rotor blade that includes the rotor extension of FIGS. 5A and B in accordance with aspects of the disclosure.
  • DETAILED DESCRIPTION
  • It is to be understood that the following disclosure provides many different embodiments, or examples, for implementing different features of various embodiments. Specific examples of components and arrangements are described below to simplify the disclosure. These are, of course, merely examples and are not intended to be limiting. In addition, the disclosure may repeat reference numerals and/or letters in the various examples. This repetition is for the purpose of simplicity and clarity and does not in itself dictate a relationship between the various embodiments and/or configurations discussed.
  • In the specification, reference may be made to the spatial relationships between various components and to the spatial orientation of various aspects of components as the devices are depicted in the attached drawings. However, as will be recognized by those skilled in the art after a complete reading of the present disclosure, the devices, members, apparatuses, etc. described herein may be positioned in any desired orientation. Thus, the use of terms such as “above,” “below,” “upper,” “lower,” or other like terms to describe a spatial relationship between various components or to describe the spatial orientation of aspects of such components should be understood to describe a relative relationship between the components or a spatial orientation of aspects of such components, respectively, as the device described herein may be oriented in any desired direction.
  • FIG. 1 illustrates an example of a rotorcraft 100. Rotorcraft 100 includes a fuselage 102, a main rotor system 110 with rotor blades 120, and a tail rotor system 112 with tail rotor blades 122. An engine within fuselage 102 supplies main rotor system 110 and tail rotor system 112 with torque to rotate rotor blades 120 and tail rotor blades 122. A fairing 130 covers a rotor hub 134 (see FIG. 2) that couples rotor blades 120 to a mast 132. Fairing 130 improves the aerodynamic efficiency of rotorcraft 100 by reducing drag of rotor hub 134. As illustrated in FIG. 1, rotorcraft 100 includes four rotor blades 120. In other aspects, rotorcraft 100 could include as few as two or three rotor blades 120 or more than four rotor blades 120 (e.g., five, six, etc.). Landing gear 104 extend from fuselage 102 and support rotorcraft 100 when rotorcraft 100 is landing or when rotorcraft 100 is at rest on the ground. Rotorcraft 100 is not meant to be limiting. Aspects of the disclosure apply to other rotorcraft as well.
  • Generally speaking, the faster a rotor blade moves through the air and the greater an angle of attack of the rotor blade, the more lift that is generated. It will be appreciated that the speed of a rotor blade increases along a length of the rotor blade (known as the asymmetry of lift). In practical terms, the portion of a rotor blade proximal to the rotor hub tends to produce less lift (absent changes to the angle of attack resulting from specific rotor blade geometries) than the distal portion of a rotor blade due to the disparity in speed between the proximal and distal portions. This disclosure recognizes that a portion of the rotor blade proximal to the yoke/rotor hub can be replaced with a rotor extension that produces little to no lift without having a detrimental effect upon the amount of lift produced by the rotor blade. Replacing some of the proximal portion of the rotor blade with a rotor extension reduces drag to improve the aerodynamic efficiency of the aircraft, which is particularly desirable for high-speed helicopters.
  • In some aspects, utilizing rotor extensions can also reduce a cost of each rotor blade as some high-performance rotorcrafts utilize rotor blades made of expensive materials (e.g., composites). Costs are reduced because less material is needed to manufacture the rotor blade due to its shortened length and/or because the proximal portions of a rotor blade often comprise more complex shapes that are more costly to manufacture. Utilizing rotor extensions also allows for the fairing covering the rotor hub to be packaged more tightly and with smaller openings or cut-outs for the rotor blades as the cross-section of the rotor extension can be made smaller than the cross-section of a conventional rotor blade that attaches to the rotor hub without a rotor extension. Utilizing a rotor extension also creates a pivot point for blade fold that is positioned farther from the rotor hub, which allows the rotor blade to fully clear the rotor hub assembly for a compact blade fold. In some aspects, rotor blade 120 can be folded by removing one or more fasteners at an end of the rotor extension and pivoting rotor blade 120 about a remaining fastener.
  • FIGS. 2A and 2B are top and side views, respectively, of main rotor system 110 according to aspects of the disclosure. Main rotor system 110 includes a fairing 130 that encloses rotor hub 134 to reduce the drag of main rotor system 110. Each rotor blade 120 is coupled to rotor hub 134 via a rotor extension 124. In various aspects, rotor extension 124 may be coupled to the yoke, mast, or other rotating component. Fairing 130 includes cut-outs 126 that permit rotor extensions 124 to pass through. Each cut-out 126 is dimensioned to accommodate a range of motion of the rotor extension 124 that passes therethrough. For example, during flight, rotor blades 120 pivot about their coupling to rotor hub 134 as a result of various dynamic forces such as flapping, coning, lead/lag, pitch, and the like. Cut-outs 126 are dimensioned to be just large enough to allow for the various movements of rotor blades 120 while minimizing the size of cut-outs 126 to improve the aerodynamic efficiency of fairing 130.
  • FIGS. 3A and 3B are perspective views of rotor extension 124. FIG. 3A illustrates an uninstalled rotor extension 124 and FIG. 3B illustrates rotor extension 124 attached to rotor blade 120. Each rotor extension 124 includes a first connector 136, a shaft 138, and a second connector 140. As illustrated in FIGS. 3A and 3B, first connector 136 is a tongue 136 and second connector 140 is a clevis 140. In other aspects, first and second connectors may comprise other connector types. In some aspects, rotor extension 124 may include a damper mount 142 attached to shaft 138 or clevis 140 for attaching a damper to rotor extension 124. In some aspects, shaft 138 or clevis 140 may include a pitch horn that couples to a pitch link to control a pitch of rotor blade 120. Rotor extension 124 may be made of various materials, including titanium, steel, aluminum, metal matrix composite, composites, and the like.
  • Tongue 136 includes one or more mounting holes 144 that receive fasteners (e.g., a pin, a screw, a bolt, and the like) to secure rotor extension 124 to rotor blade 120. As illustrated in FIGS. 3A and 3B, tongue 136 is configured to fit inside of an opening in an end of rotor blade 120. As illustrated in FIG. 3B, the opening in the end of rotor extension 124 is formed so that an outer profile of rotor blade 120 is not altered and an outer surface of rotor blade 120 remains smooth and unobstructed by connection of rotor extension 124 to rotor blade 120. Rotor blade 120 includes corresponding mounting holes 146 that align with the one or more mounting holes 144. In other aspects, tongue 136 may instead attached to an exterior portion of rotor blade 120.
  • Rotor blade 120 may be folded about tongue 136 by removing a fastener from the connection between rotor blade 120 and tongue 136. Rotor extension 124 allows for a compact blade fold as the pivot point about tongue 136 is sufficiently far away from rotor hub 134 to allow the rotor blades 120 to clear fairing 130.
  • Shaft 138 joins tongue 136 with clevis 140. In some aspects, shaft 138 is a hollow tube to reduce a weight of rotor extension 124. Clevis 140 is disposed on an end of shaft 138 opposite tongue 136 and couples to rotor hub 134. In a typical aspect, rotor extension 124 couples to rotor hub 134 via a bearing assembly that includes an inboard beam and a centrifugal force bearing. As illustrated in FIGS. 3A and 3B, clevis 140 is arranged generally vertically. It will be appreciated that clevis 140 could be arranged horizontally or at an angle between horizontal and vertical as needed to allow for rotor extension 124 to attach to a particular rotor hub. In some aspects, clevis 140 could be replaced with an alternative connection suited to a particular rotor hub.
  • Shaft 138 may have a variety of cross-sections, including circular, elliptical, rectangular, polygonal, and the like. As illustrated in FIGS. 3A and 3B, shaft 138 has a circular cross-section. Shaft 138 has a cross-section that is notably smaller than that of a conventional rotor blade (e.g., see FIG. 4), which allows the size of cut-outs 126 to be minimized. Having a circular cross-section enables rotor extension 124 to maintain its projected frontal area regardless of the pitch of the rotor blade 120, resulting in a consistent amount of drag generated by shaft 138 regardless of pitch angle. It has been determined that the benefits of minimizing the size of the opening of cut-out 126 outweighs the benefits of using a more aerodynamic shaft 138. For example, using an elliptical cross-section on shaft 138 improves the aerodynamics of the portion of shaft 138 that is outside fairing 130. However, an elliptical cross-section increases the size of cut-out 126. The increase in drag resulting from the larger cut-out 126 results in a net increase in the drag acting on rotorcraft 100.
  • In some aspects, shaft 138 comprises more than one cross-section to overcome the potential drawbacks of using an elliptical cross-section. For example, a portion of shaft 138 that passes through cut-out 126 may comprise a first cross-section (e.g., circular) and a portion of shaft 138 disposed outside of fairing 130 may comprise a second cross-section (e.g., elliptical). Using a circular cross-section for the first cross-section minimizes a size of cut-out 126 and using an elliptical cross-section for the second cross-section optimizes aerodynamics of the portion of shaft 138 disposed outside of fairing 130.
  • In some aspects, shaft 138 comprises a first cross-section (e.g., circular) and a portion of shaft 138 located outside of fairing 130 includes an extension fairing 178 fitted to shaft 138 to improve the aerodynamics of the portion of shaft 138 located outside fairing 130. Extension fearing 178 may comprise an elliptical shape, a blade-like shape, or other aerodynamic shape to minimize the drag created by the portion of shaft 138 located outside fairing 130. Extension fairing 178 can be a removable piece that attaches to rotor extension 124 via fasteners, adhesives, and the like, or can be integrally formed as a part of rotor extension 124.
  • In various aspects, tongue 136 and clevis 140 are set at an angle relative to each other to add an amount of blade twist to rotor extension 124. Blade twist describes a geometric twist along a length of the rotor blade to change the rotor blade's pitch along the length of the rotor blade to combat asymmetry of lift. Pitch is decreased as the distance from the hub increases to even out the amount of thrust generated along the length of the rotor blade. FIGS. 3A and 3B illustrate that a face 137 of tongue 136 and a face 141 of clevis 140 are arranged at an angle relative to one another (e.g., not parallel to one another) to introduce an amount of blade twist to rotor blade 120. In some aspects, approximately 10 degrees of blade twist as added via extension 124. In other aspects, more than 10 degrees or less than 10 degrees of blade twist may be added by rotor extension 124. Introducing blade twist via rotor extension 124 may be desirable as the amount of blade twist added by rotor extension 124 does not need to be added to rotor blade 120, which is typically made from expensive composite materials. To incorporate blade twist into the design of rotor blade 120 adds complexity to the structure of rotor blade 120, adding to its cost. In some aspects, rotor extension 124 may be designed without any blade twist, with faces 137 and 141 parallel to one another.
  • FIG. 4 is a top view of a conventional rotor blade 121 overlaid on top of a combination of rotor extension 124 attached to rotor blade 120. FIG. 4 illustrates the reduction in surface area, and thus the reduction in drag, afforded by using rotor extension 124.
  • FIGS. 5A-5B illustrate a rotor extension 200 according to aspects of the disclosure. In various aspects, rotor extension 200 may be used in place of rotor extension 124. Compared to rotor extension 124, rotor extension 200 has a flat, blade-like shape. Rotor extension 200 reduces drag compared to a conventional rotor blade by having a lower profile shape (e.g., see FIG. 6). Each rotor extension 200 includes a tongue 202 and a tongue 204 that are disposed on opposite ends of an extension portion 206. Rotor extension 200 may be made of various materials, including titanium, steel, aluminum, metal matrix composite, composites, and the like. In some aspects, rotor extension 200 is made from carbon fiber, fiberglass, or a combination of the two.
  • Tongue 202 includes one or more mounting holes that receive fasteners to secure rotor extension 200 to rotor blade 120 and tongue 204 includes one or more mounting holes that receive fasteners to secure rotor extension 200 to a yoke attachment 208. Fasteners can be pins, screws, bolts, and the like. Yoke attachment 208 includes corresponding mounting holes that align with the one or more mounting holes of tongue 204. As illustrated in FIGS. 5A and 5B, yoke attachment 208 comprises a body portion 210 that couples to rotor hub to secure rotor blade 120 thereto. In a typical aspect, yoke attachment 208 couples to the rotor hub via a bearing assembly, such as a centrifugal bearing assembly.
  • In various aspects, tongue 202 and tongue 204 are set at an angle relative to each other to add an amount of blade twist to rotor extension 200 (best seen in FIG. 5B). Introducing blade twist via rotor extension 200 may be desirable as the amount of blade twist added by rotor extension 200 does not need to be added to rotor blade 120, simplifying the shape of rotor blade 120, which is typically made from expensive composite materials. To incorporate blade twist into the design of rotor blade 120 adds complexity to the structure of rotor blade 120, adding to its cost. In some aspects, rotor extension 200 may be designed without any blade twist.
  • FIG. 6 is a perspective view of a conventional rotor blade 121 overlaid on top of a combination of rotor extension 200 attached to rotor blade 120. FIG. 6 illustrates the reduction in surface area/size, and thus the reduction in drag, afforded by using rotor extension 200.
  • Depending on the embodiment, certain acts, events, or functions of any of the algorithms, methods, or processes described herein can be performed in a different sequence, can be added, merged, or left out altogether (e.g., not all described acts or events are necessary for the practice of the algorithms, methods, or processes). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially. Although certain computer-implemented tasks are described as being performed by a particular entity, other embodiments are possible in which these tasks are performed by a different entity.
  • Conditional language used herein, such as, among others, “can,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or states are included or are to be performed in any particular embodiment.
  • The term “substantially” is defined as largely but not necessarily wholly what is specified (and includes what is specified; e.g., substantially 90 degrees includes 90 degrees and substantially parallel includes parallel), as understood by a person of ordinary skill in the art. In any disclosed embodiment, the terms “substantially,” “approximately,” “generally,” “generally in the range of,” and “about” may be substituted with “within [a percentage] of” what is specified, as understood by a person of ordinary skill in the art. For example, within 1%, 2%, 3%, 5%, and 10% of what is specified herein.
  • While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As will be recognized, the processes described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. The scope of protection is defined by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims (20)

What is claimed is:
1. A rotor extension for a rotorcraft, the rotor extension comprising:
a first connector configured to attach the rotor extension to a rotor blade;
a second connector configured to attach the rotor extension to a rotor hub of the rotorcraft;
a shaft disposed between the first and second connectors; and
a damper mount attached to the second connector.
2. The rotor extension of claim 1, wherein the shaft is hollow.
3. The rotor extension of claim 1, wherein the first connector is a tongue and the second connector is a clevis.
4. The rotor extension of claim 3, wherein the tongue comprises a mounting hole configured to receive a fastener to secure the rotor blade to the rotor extension.
5. The rotor extension of claim 1, comprising an extension fairing disposed on the shaft.
6. The rotor extension of claim 1, wherein the first connector and the second connector are disposed on the shaft at angle relative to one another to introduce an amount of blade twist to the rotor blade.
7. The rotor extension of claim 1, wherein the first and second connector are aligned relative to each other so that no blade twist is introduced by the rotor extension.
8. The rotor extension of claim 1, wherein the shaft comprises a circular cross-section.
9. The rotor extension of claim 1, wherein the first connector is configured to fit within an opening of an end of the rotor blade.
10. The rotor extension of claim 1, wherein the first connector is configured to attach to an outer portion of the rotor blade.
11. A rotorcraft comprising a low-drag rotor extension, the rotorcraft comprising:
a rotor hub coupled to a mast;
a plurality of rotor extensions, each rotor extension configured to secure a rotor blade to the rotor hub, each rotor extension comprising:
a first connector configured to attach the rotor extension to a rotor blade;
a second connector configured to attach the rotor extension to the rotor hub;
a shaft disposed between the first and second connectors; and
a damper mount attached to the second connector; and
a fairing enclosing at least a portion of the rotor hub.
12. The rotorcraft of claim 11, wherein the shaft is hollow.
13. The rotorcraft of claim 11, wherein the first connector comprises a tongue and the second connector comprises a clevis.
14. The rotorcraft of claim 11, wherein the first connector comprises a mounting hole configured to receive a fastener to secure the rotor blade to a rotor extension of the plurality of rotor extensions.
15. The rotorcraft of claim 11, comprising an extension fairing disposed on a portion of the shaft located outside the fairing.
16. The rotorcraft of claim 11, wherein the first connector and the second connector are set at an angle relative to each other to add an amount of blade twist to a rotor extension of the plurality of rotor extensions.
17. The rotorcraft of claim 11, wherein the first connector and the second connector are aligned relative to each other so that no blade twist is introduced by a rotor extension of the plurality of rotor extensions.
18. The rotorcraft of claim 11, wherein the shaft comprises a circular cross-section.
19. The rotorcraft of claim 11, wherein the first connector is configured to fit within an opening of an end of the rotor blade.
20. The rotorcraft of claim 11, wherein the first connector is configured to attach to an outer portion of the rotor blade.
US16/447,421 2019-06-20 2019-06-20 Low-drag rotor blade extension Abandoned US20200398978A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/447,421 US20200398978A1 (en) 2019-06-20 2019-06-20 Low-drag rotor blade extension
US17/025,371 US11358711B2 (en) 2019-06-20 2020-09-18 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/447,421 US20200398978A1 (en) 2019-06-20 2019-06-20 Low-drag rotor blade extension

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US17/025,371 Continuation US11358711B2 (en) 2019-06-20 2020-09-18 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
US17/025,371 Division US11358711B2 (en) 2019-06-20 2020-09-18 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

Publications (1)

Publication Number Publication Date
US20200398978A1 true US20200398978A1 (en) 2020-12-24

Family

ID=74037792

Family Applications (2)

Application Number Title Priority Date Filing Date
US16/447,421 Abandoned US20200398978A1 (en) 2019-06-20 2019-06-20 Low-drag rotor blade extension
US17/025,371 Active 2039-07-03 US11358711B2 (en) 2019-06-20 2020-09-18 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/025,371 Active 2039-07-03 US11358711B2 (en) 2019-06-20 2020-09-18 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

Country Status (1)

Country Link
US (2) US20200398978A1 (en)

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100491349C (en) 2001-08-10 2009-05-27 盐野义制药株式会社 Antiviral agent
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
EP1725554A1 (en) 2004-03-09 2006-11-29 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Hiv integrase inhibitors
EP1973906A1 (en) 2004-12-23 2008-10-01 Virochem Pharma Inc. Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
ES2437268T3 (en) 2005-04-28 2014-01-09 Viiv Healthcare Company Polycyclic carbamoylpyridone derivative that has HIV integrase inhibitory activity
JP2006342115A (en) 2005-06-10 2006-12-21 Shionogi & Co Ltd Polycyclic compound having hiv integrase inhibition activity
CA2626956A1 (en) 2005-10-27 2007-05-03 Shionogi & Co., Ltd. Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
EP2465858B1 (en) 2008-07-25 2013-12-25 VIIV Healthcare Company Process for preparing a pyrido[1,2-a]pyrrolo[1',2':3,4]imidazo[1,2-d]pyrazine-8-carboxamide derivative
SG10201914059WA (en) * 2008-10-22 2020-03-30 Array Biopharma Inc Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
JP5572168B2 (en) 2008-12-11 2014-08-13 ビーブ・ヘルスケア・カンパニー Process for producing carbamoylpyridone HIV integrase inhibitor and intermediate
TWI518084B (en) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 Process for pyrone and pyridone derivatives
WO2011011483A1 (en) 2009-07-22 2011-01-27 Glaxosmithkline Llc Chemical compounds
SG183484A1 (en) 2010-02-26 2012-09-27 Japan Tobacco Inc 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
TWI582097B (en) 2010-03-23 2017-05-11 Viiv醫療保健公司 Process for preparing carbamoylpyridone derivatives and intermediates
US9216995B2 (en) 2010-04-12 2015-12-22 Shionogi & Co., Ltd. Pyridone derivative having integrase inhibitory activity
BR112013002461A2 (en) 2010-08-05 2016-05-24 Shionogi & Co method for producing a compound, and crystal of a compound
WO2012095388A2 (en) 2011-01-10 2012-07-19 Universität Zürich Compounds for treatment of feline leukemia in felidae
US20140213553A1 (en) 2011-05-03 2014-07-31 Concert Pharmaceuticals Inc. Carbamoylpyridone derivatives
US9206197B2 (en) 2011-09-14 2015-12-08 Mapi Pharma Ltd. Amorphous form of dolutegravir
EP2774928B1 (en) 2011-10-12 2017-08-30 Shionogi & Co., Ltd. Polycyclic pyridone derivative having integrase-inhibiting activity
EP2931730B1 (en) 2012-12-17 2019-08-07 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
US9216996B2 (en) 2012-12-21 2015-12-22 Gilead Sciences, Inc. Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
JP6320039B2 (en) 2012-12-27 2018-05-09 日本たばこ産業株式会社 Substituted spiropyrido [1,2-a] pyrazine derivatives and their pharmaceutical use as HIV integrase inhibitors
DK2997033T3 (en) 2013-05-17 2018-01-29 Merck Sharp & Dohme CONDENSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
WO2014200880A1 (en) 2013-06-13 2014-12-18 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
NO2865735T3 (en) 2013-07-12 2018-07-21
JP6411491B2 (en) 2013-07-12 2018-10-24 ギリアード サイエンシス インコーポレーテッド Polycyclic carbamoylpyridone compounds and their use for treating HIV infection
WO2015039348A1 (en) 2013-09-23 2015-03-26 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
MD4794B1 (en) 2013-09-27 2022-02-28 Merck Sharp & Dohme Corp Substituted quinolizine derivatives useful as HIV integrase inhibitors
WO2015089847A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
EP3196201B1 (en) 2014-08-22 2021-04-28 Shionogi & Co., Ltd. Polycyclic pyridone derivative having integrase-inhibiting activity
WO2016090545A1 (en) 2014-12-09 2016-06-16 Merck Sharp & Dohme Corp. Spirocyclic heterocycle compounds useful as hiv integrate inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
JOP20190130A1 (en) 2016-12-02 2019-06-02 Merck Sharp & Dohme Tetracyclic heterocycle compounds useful as hiv integrase inhibitors

Also Published As

Publication number Publication date
US11358711B2 (en) 2022-06-14
US20210009262A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
US9453516B2 (en) Blade rotary assembly with aerodynamic outer toroid spoiler for a shrouded propulsion rotary assembly
US5131604A (en) Helicopter antitorque device
RU2570971C2 (en) Flying vehicle propeller encased in cowl and rotorcraft
CA2056289C (en) Shroud-fin integration shelf for a helicopter empennage structure
EP3354559A1 (en) A thrust producing unit with at least two rotor assemblies and a shrouding
JPS632799A (en) Device for controlling azimuth and stability of rotary-wing aircraft
US11447243B2 (en) Helicopter with anti-torque system, related kit and methods
JPH06509765A (en) Ducted fans and pitch control devices for rotorcraft tail rotor blades
EP0508026B1 (en) Integrated helicopter empennage structure
US20160144955A1 (en) Rotary wing aircraft having a non-ducted tail rotor with at least five blades
US20110186679A1 (en) Aircraft with at least two propeller drives arranged at a distance from one another in the span width direction of the wings
US9963226B2 (en) Tail assembly for a rotorcraft, rotorcraft and method of manufacture of a strengthened tail assembly
US5927948A (en) Propeller
US20200398978A1 (en) Low-drag rotor blade extension
US11053001B2 (en) Low-drag fairing and rotor assembly
US20170088258A1 (en) Rotor head, a rotor, and a rotorcraft
JP2003175897A (en) Twin ducted fan type tail rotor blade for rotary-wing aircraft
US10589842B2 (en) Spinners for use on tiltrotor aircraft
US11440651B1 (en) Spherical bearing centrifugal force retention link
US20180002002A1 (en) Rotor assembly including a one piece molding rotor hub
US20050230521A1 (en) Powerchute apparatus
US10875639B2 (en) Bi-planer rotor blade
US20240140601A1 (en) Rotorcraft with a ducted tail rotor supported by a stator
US20220126991A1 (en) Biased tension-torsion strap
US20220306291A1 (en) Aircraft

Legal Events

Date Code Title Description
AS Assignment

Owner name: BELL HELICOPTER TEXTRON INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAULSON, JARED MARK;SHIMEK, GLENN ALAN;DONOVAN, TOM;AND OTHERS;SIGNING DATES FROM 20190613 TO 20190617;REEL/FRAME:049596/0458

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

AS Assignment

Owner name: BELL TEXTRON INC., TEXAS

Free format text: CHANGE OF NAME;ASSIGNOR:BELL HELICOPTER TEXTRON INC.;REEL/FRAME:055606/0241

Effective date: 20190611

Owner name: TEXTRON INNOVATIONS INC., RHODE ISLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BELL TEXTRON RHODE ISLAND INC.;REEL/FRAME:055609/0424

Effective date: 20200101

Owner name: BELL TEXTRON RHODE ISLAND INC., RHODE ISLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BELL TEXTRON INC.;REEL/FRAME:055609/0001

Effective date: 20200101

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION